SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Exactus, Inc. – ‘10-Q’ for 3/31/20 – ‘EX-32.1’

On:  Tuesday, 6/30/20, at 2:10pm ET   ·   As of:  6/29/20   ·   For:  3/31/20   ·   Accession #:  1654954-20-7148   ·   File #:  1-38190   ·   Correction:  This Filing’s Metadata was Corrected ® and Changed as of 6/30/20 by the SEC on 7/7/20.

Previous ‘10-Q’:  ‘10-Q’ on 11/14/19 for 9/30/19   ·   Next:  ‘10-Q’ on 8/19/20 for 6/30/20   ·   Latest:  ‘10-Q’ on 11/14/23 for 9/30/23   ·   1 Reference:  By:  Panacea Life Sciences Holdings, Inc. – ‘10-K/A’ on 4/23/21 for 12/31/20

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/29/20  Exactus, Inc.                     10-Q®       3/31/20   68:7M                                     Blueprint/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    671K 
 2: EX-10.1     Loan Agreement and Note With the U.S. Small         HTML     27K 
                Business Administration                                          
 3: EX-31.1     Certification Pursuant to Rule 13A-14(A)/15D-14(A)  HTML     29K 
                Certifications Section 302 of the Sarbanes-Oxly                  
                Act of 2002                                                      
 4: EX-31.2     Certification Pursuant to Rule 13A-14(A)/15D-14(A)  HTML     29K 
                Certifications Section 302 of the Sarbanes-Oxly                  
                Act of 2002                                                      
 5: EX-32.1     Certificate Pursuant to Section 18 U.S.C. Pursuant  HTML     24K 
                to Section 906 of the Sarbanes-Oxley Act of 2002                 
12: R1          Document and Entity Information                     HTML     54K 
13: R2          Condensed Balance Sheets (Unaudited)                HTML    185K 
14: R3          Condensed Balance Sheets (Parenthetical)            HTML     58K 
15: R4          Condensed Statements of Operations and              HTML    122K 
                Comprehensive Loss (Unaudited)                                   
16: R5          Condensed Consolidated Statements of Stockholders'  HTML    134K 
                Equity (Deficit)                                                 
17: R6          Condensed Consolidated Statements of Cash Flows     HTML    156K 
                (Unaudited)                                                      
18: R7          Nature of Organization                              HTML     34K 
19: R8          Summary of Significant Accounting Policies          HTML     87K 
20: R9          Acquisition of Assets and Ownership in Exactus One  HTML     60K 
                World, Llc                                                       
21: R10         Inventory                                           HTML     26K 
22: R11         Property and Equipment                              HTML     30K 
23: R12         Intangible Asset                                    HTML     31K 
24: R13         Operating Lease Right-Of-Use Assets and Operating   HTML     57K 
                Lease Liabilities                                                
25: R14         Notes Payable - Related Parties                     HTML     26K 
26: R15         Convertible Notes Payable                           HTML     48K 
27: R16         Stockholders' Equity (Deficit)                      HTML     78K 
28: R17         Commitments and Contingencies                       HTML     68K 
29: R18         Related Party Considerations                        HTML     35K 
30: R19         Concentration of Revenue and Supplier               HTML     25K 
31: R20         Subsequent Events                                   HTML     40K 
32: R21         Summary of Significant Accounting Policies          HTML    148K 
                (Policies)                                                       
33: R22         Summary of Significant Accounting Policies          HTML     38K 
                (Tables)                                                         
34: R23         Acquisition of Assets and Ownership in Exactus One  HTML     29K 
                World, Llc (Tables)                                              
35: R24         Inventory (Tables)                                  HTML     27K 
36: R25         Property and Equipment (Tables)                     HTML     28K 
37: R26         Intangible Asset (Tables)                           HTML     32K 
38: R27         Operating Lease Right-Of-Use Assets and Operating   HTML     53K 
                Lease Liabilities (Tables)                                       
39: R28         Convertible Notes Payable (Tables)                  HTML     45K 
40: R29         Stockholders' Equity (Deficit) (Tables)             HTML     46K 
41: R30         Nature of Organization (Details Narrative)          HTML     24K 
42: R31         Summary of Significant Accounting Policies          HTML     28K 
                (Details)                                                        
43: R32         Summary of Significant Accounting Policies          HTML     27K 
                (Details 1)                                                      
44: R33         Summary of Significant Accounting Policies          HTML     32K 
                (Details 2)                                                      
45: R34         Summary of Significant Accounting Policies          HTML     62K 
                (Details Narrative)                                              
46: R35         Acquisition of Assets and Ownership in Exactus One  HTML     44K 
                World, Llc (Details)                                             
47: R36         Inventory (Details)                                 HTML     27K 
48: R37         Property and Equipment (Details)                    HTML     43K 
49: R38         Property and Equipment (Details Narrative)          HTML     23K 
50: R39         Intangible Asset (Details)                          HTML     38K 
51: R40         Intangible Asset (Details 1)                        HTML     31K 
52: R41         Intangible Asset (Details Narrative)                HTML     24K 
53: R42         Operating Lease Right-Of-Use Assets and Operating   HTML     28K 
                Lease Liabilities (Details)                                      
54: R43         Operating Lease Right-Of-Use Assets and Operating   HTML     26K 
                Lease Liabilities (Details 1)                                    
55: R44         Operating Lease Right-Of-Use Assets and Operating   HTML     41K 
                Lease Liabilities (Details 2)                                    
56: R45         Operating Lease Right-Of-Use Assets and Operating   HTML     43K 
                Lease Liabilities (Details 3)                                    
57: R46         Notes Payable - Related Parties (Details            HTML     29K 
                Narrative)                                                       
58: R47         Convertible Notes Payable (Details)                 HTML     44K 
59: R48         Convertible Notes Payable (Details 1)               HTML     30K 
60: R49         Convertible Notes Payable (Details Narrative)       HTML     27K 
61: R50         Stockholders' Equity (Deficit) (Details)            HTML     55K 
62: R51         Stockholders' Equity (Deficit) (Details 1)          HTML     51K 
63: R52         Stockholders' Equity (Deficit) (Details 2)          HTML     31K 
64: R53         Stockholders' Equity (Deficit) (Details 3)          HTML     36K 
65: R54         Stockholders' Equity (Deficit) (Details Narrative)  HTML     55K 
67: XML         IDEA XML File -- Filing Summary                      XML    123K 
66: EXCEL       IDEA Workbook of Financial Reports                  XLSX    110K 
 6: EX-101.INS  XBRL Instance -- exdi-20200331                       XML   1.09M 
 8: EX-101.CAL  XBRL Calculations -- exdi-20200331_cal               XML    172K 
 9: EX-101.DEF  XBRL Definitions -- exdi-20200331_def                XML    353K 
10: EX-101.LAB  XBRL Labels -- exdi-20200331_lab                     XML    827K 
11: EX-101.PRE  XBRL Presentations -- exdi-20200331_pre              XML    659K 
 7: EX-101.SCH  XBRL Schema -- exdi-20200331                         XSD    171K 
68: ZIP         XBRL Zipped Folder -- 0001654954-20-007148-xbrl      Zip    134K 


‘EX-32.1’   —   Certificate Pursuant to Section 18 U.S.C. Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  exdi_ex321  
 
 
Exhibit 32.1
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND
CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the quarterly Report of Exactus, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2020 filed with the Securities and Exchange Commission (the “Report”), I, Emiliano Aloi, Interim Chief Executive Officer, and I, Kenneth Puzder, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
1.
The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
 
2.
The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.
 
 
By:
/s/ Emiliano Aloi
Name:
Emiliano Aloi
Title:
Principal Executive Officer
Date:
 
 
By:
/s/ Kenneth Puzder
Name:
Kenneth Puzder
Title:
Principal Financial Officer
Date:
 
This certification has been furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. Principal Financial Officer
 
 
 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Corrected on:7/7/20
Filed on / Changed on:6/30/2010-Q,  8-K,  NT 10-Q
Filed as of:6/29/20NT 10-Q
For Period end:3/31/20NT 10-Q
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/23/21  Panacea Life Sciences Holdin… Inc 10-K/A     12/31/20   77:7M                                     Blueprint/FA
Top
Filing Submission 0001654954-20-007148   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 9:01:36.1pm ET